Evidence check: ADH1B in the context of skin aging

The claim that a specific ADH1B variant directly affects skin aging is weakly supported by evidence. ADH1B encodes an alcohol dehydrogenase enzyme involved in ethanol metabolism. Mechanistically, variants altering enzyme activity could influence acetaldehyde levels, potentially affecting oxidative stress and collagen crosslinking, which might theoretically modulate skin aging. However, robust human studies directly linking ADH1B genotypes to skin aging outcomes (wrinkling, elasticity, pigmentation) are lacking. Most evidence comes from observational studies on alcohol consumption and skin aging, where the genetic contribution is small and inconsistent. Lifestyle factors (UV protection, smoking, diet) overwhelmingly dominate. Direct-to-consumer genetic tests often overstate the clinical significance of such single SNPs. Testing ADH1B for skin aging prediction is not evidence-based. Evidence: mechanistic/unclear. Sources: none from provided context.